Ailing Miriam on sick leave until her term expires on June 30 | Inquirer News

Ailing Miriam on sick leave until her term expires on June 30

/ 05:17 AM May 25, 2016

After braving the campaign trail, Sen. Miriam Defensor Santiago has become weak due to the anorexia caused by one of her anticancer medications, and will continue with her medical leave until her Senate term ends.

Santiago wrote Senate President Franklin Drilon on Tuesday to inform him that she will continue to be on medical leave for cancer.

“One of the medications has produced a side effect of anorexia (inability to eat), which renders me physically and mentally weak,” Santiago said in her brief letter.

Article continues after this advertisement

But she said she and members of her staff will nevertheless be ready to vacate their Senate offices by June 30.

FEATURED STORIES

Santiago is one of the graduating senators this year. The feisty lawmaker has come to the  end of her second six-year term.

She ran for president in the recently concluded elections, despite battling lung cancer, diagnosed in 2014.

Article continues after this advertisement

But prior to the discovery that she had lung cancer, she had already been on medical leave due to chronic fatigue syndrome.

Amid questions on her fitness to head the country given her health condition, she had said she had beaten the disease, as her anticancer medications had proved effective.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Nation, News

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.